Shares of Enovix Corporation (NASDAQ:ENVX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $12.6364.
A number of research analysts have issued reports on the company. B. Riley Financial reduced their price target on Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, March 2nd. Oppenheimer reduced their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. Wells Fargo & Company set a $6.00 price target on Enovix in a research report on Thursday, March 12th. Benchmark reduced their price target on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Finally, Bank of America started coverage on Enovix in a research note on Thursday, March 12th. They issued a “neutral” rating and a $6.00 price objective on the stock.
Read Our Latest Research Report on ENVX
Institutional Trading of Enovix
Enovix Trading Down 7.8%
Shares of ENVX stock opened at $6.75 on Wednesday. The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97. Enovix has a 1 year low of $4.61 and a 1 year high of $16.49. The stock has a fifty day moving average of $6.57 and a two-hundred day moving average of $6.77. The firm has a market capitalization of $1.47 billion, a PE ratio of -8.13 and a beta of 2.27.
Enovix (NASDAQ:ENVX – Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The company had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. During the same quarter in the previous year, the firm posted ($0.15) EPS. The firm’s quarterly revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, research analysts expect that Enovix will post -0.79 EPS for the current year.
About Enovix
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Stories
- Five stocks we like better than Enovix
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
